0 145

Cited 0 times in

A phase Ib, open-label study evaluating the safety and efficacy of ipatasertib + rucaparib in patients with metastatic castration-resistant prostate cancer

Authors
 David William Pook  ;  Daniel M. Geynisman  ;  Joan Carles  ;  Filippo G. De Braud  ;  Anthony M. Joshua  ;  Jose Luis Perez-Gracia  ;  Casilda Llácer Pérez  ;  Sang Joon Shin  ;  Bruno Fang  ;  Minal A. Barve  ;  Marco Maruzzo  ;  Sergio Bracarda  ;  Miso Kim  ;  Yannick Kerloeguen  ;  Jorge Daniel Gallo  ;  Sophia Maund  ;  Adam Harris  ;  Kuan-Chieh Huang  ;  Dhruvitkumar S. Sutaria  ;  Howard Gurney 
Citation
 JOURNAL OF CLINICAL ONCOLOGY, Vol.40(6) : S95, 2022-02 
Journal Title
JOURNAL OF CLINICAL ONCOLOGY
ISSN
 0732-183X 
Issue Date
2022-02
Full Text
https://ascopubs.org/doi/10.1200/JCO.2022.40.6_suppl.095
DOI
10.1200/JCO.2022.40.6_suppl.095
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Shin, Sang Joon(신상준) ORCID logo https://orcid.org/0000-0001-5350-7241
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194318
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links